Balancing the Scales: What the Rise of GLP-1s Means for Employers Today
Glucagon-like peptide-1 agonists (GLP-1s) are a class of medications originally intended for the treatment of type 2 diabetes and obesity. However, in the last year, they’ve become known for their impact on the polarizing topic of weight loss. With GLP-1s, patients can successfully lose weight without having to do activities traditionally associated with losing weight, […]